Invesco FTSE RAFI Developed Markets ex-U.S. ETF (PXF) is an exchange-traded fund that seeks to track the performance of the RAFI Fundamental Select Developed ex US 1000 Index, employing a fundamentals-weighted approach to provide exposure to large- and mid-cap equities in developed markets outside the United States; the fund normally invests at least 90% of its total assets in securities comprising the index or American Depository Receipts (ADRs) based on those securities, with constituent selection emphasizing fundamental metrics such as dividends, free cash flow, book value, and sales rather than traditional market capitalization weighting. Core holdings span diversified sectors including financials, industrials, consumer discretionary, and materials, featuring prominent non-U.S. companies like Novartis AG, Shell Plc, and HSBC Holdings Plc, while maintaining a broad portfolio of approximately 1,000 stocks rebalanced quarterly in March, June, September, and December to mitigate sector bets and favor larger firms over small-caps. The ETF targets institutional and retail investors seeking international developed market diversification with a value tilt, operating primarily in Europe, Japan, Australia, and Canada.
Invesco Ltd., the fund's sponsor and investment manager, was founded in 1978 through the divestiture of Citizens & Southern National Bank's money management operations and is headquartered at 1331 Spring Street NW, Suite 2500, Atlanta, Georgia, with global operations across 20 countries.
Prior to March 24, 2025, the fund tracked the FTSE RAFI Developed ex-U.S. 1000 Index and operated under the name Invesco FTSE RAFI Developed Markets ex-U.S. ETF, reflecting a recent index methodology update and rebranding to align with the RAFI Fundamental Select Developed ex US 1000 Index for enhanced fundamental screening precision.